-
Impact of germline pathogenic variants in 27 cancer-predisposing genes on the risk of lymphoma
Study
JGAS000347
-
Establishment of an integrated database for clinical and genomic data in cancer
Study
JGAS000206
-
Whole exome sequencing and RNA sequencing of cervical cancer
Study
JGAS000582
-
Research of factors related to diagnosis, progression, prognosis and treatment of hepato-biliary-pancreatic malignancies
Study
JGAS000052
-
Variant allele frequency changes in TP53 predict pembrolizumab response in patients with metastatic urothelial carcinoma
Study
JGAS000622
-
Target sequencing of 27 cancer-predisposing genes and 13 renal cell carcinoma-related genes in Japanese renal cell carcinoma patients
Study
JGAS000414
-
Genomic Profiling Reveals Heterogeneous Populations of Ductal Carcinoma In Situ
Study
JGAS000202
-
Elucidation of molecular mechanism of NAFLD-HCC
Study
JGAS000311
-
Genome-wide integrative analysis of pediatric pancreatoblastoma
Study
JGAS000088
-
Homozygous inactivation of CHEK2 is linked to a familial case of multiple primary lung cancer with accompanying cancers in other organs
Study
JGAS000057
-
Genetic and transcriptional landscape of plasma cells in POEMS syndrome
Study
JGAS000150
-
Establishment of xenogfafts and cultured cell lines from clinical samples
Study
JGAS000585
-
Analysis of genomic alterations in dedifferentiated liposarcoma
Study
JGAS000182
-
Exploratory novel biomarker and resistance mechanism of milademetan, an MDM2 inhibitor, in MDM2 amplified intimal sarcoma from an open-label phase 1b/2 trial ���NCCH1806/MK004���
Study
JGAS000619
-
Genomic and Genetic Analysis of Brain Tumors and Analysis of Their Clinicopathological Significance
Study
JGAS000004
-
Comprehensive molecular and clinicopathological profiling of lung adenocarcinoma in Japanese never or light smokers
Study
JGAS000215
-
Immuno-genomic Profiling of Biopsy Specimens Predicts Neoadjuvant Chemotherapy Response in Esophageal Squamous Cell Carcinoma
Study
JGAS000535
-
Molecular analysis of diffuse cerebellar gliomas
Study
JGAS000106
-
Sequencing cancer mutations in various types of lung cancer using the long-read, portable sequencer
Study
JGAS000065
-
Genome and gene analysis of gastrointestinal cancer and elucidation of its clinicopathological significance
Study
JGAS000233
-
Mortality and risk of progression to adult T-cell leukemia/lymphoma in patients with HTLV-1-associated myelopathy/tropical spastic paraparesis
Study
JGAS000226
-
Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas
Study
JGAS000022
-
Whole exome sequencing and RNA-seq of esophageal squamous cell carcinoma
Study
JGAS000367
-
Myasthenia gravis-specific aberrant neuromuscular gene expression by medullary thymic epithelial cells in thymoma
Study
JGAS000482
-
DNA demethylation is associated with malignant progression of low-grade gliomas
Study
JGAS000146
-
intratumor heterogeneity in colorectal adenoma and carcinoma
Study
JGAS000092
-
Paediatric Hepatic International Tumour Trial (JPLT2: PHITT)
Study
JGAS000236
-
DNA methylation at HBV integrants and flanking host genomes
Study
JGAS000015
-
Genome-wide copy number analysis of neuroblastoma
Study
JGAS000046
-
Phylogenetic analysis of paired breast carcinomas identifies genetic events associated with clonal recurrence and invasive progression
Study
EGAS50000001298
-
DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded (FFPE) tissues followed by targeted sequencing
Study
EGAS50000001327
-
DEPArray-based sorting of pure carcinoma and stromal populations from formalin-fixed paraffin-embedded (FFPE) tissues followed by shallow whole genome sequencing
Study
EGAS50000001328
-
Co-culture experiment (hashed samples)
Study
EGAS50000001252
-
Deciphering the aggressive nature of morphoeic basal cell carcinoma
Study
EGAS00001001915
-
Transcriptome analysis of leiomyosarcoma
Study
EGAS50000000594
-
Targeted gene panel sequencing of leiomyosarcoma
Study
EGAS50000000595
-
Genomic and transcriptomic profiling of leiomyosarcoma
Dataset
EGAD50000000846
-
How to use the EGA search box
Documentation
discovery/metadata/search-box
-
Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: Primary phase 2 trial results with ctDNA residual disease analyses
Study
EGAS50000001195
-
MATISSE WES and bulk RNA-sequencing data
Study
EGAS50000001003
-
BCC HHI-ICI combination therapy
Dataset
EGAD50000002134
-
NIBIT-EPI-MESO study samples
Study
EGAS50000001478
-
cfMeDIP-seq for 18 patients with pleural mesothelioma
Dataset
EGAD50000002126
-
WES for 42 patients with pleural mesothelioma (Not matched)
Dataset
EGAD50000002127
-
WES for 45 patients with pleural mesothelioma (Matched)
Dataset
EGAD50000002128
-
RRBS of 58 pleural mesothelioma samples (Paired-end)
Dataset
EGAD50000002129
-
RRBS of 25 pleural mesothelioma samples (Single-end)
Dataset
EGAD50000002130
-
RNA-sequencing of 82 pleural mesothelioma samples
Dataset
EGAD50000002131
-
Spatial profiling of hepatocellular carcinoma identifies distinct tumor and immune micro-ecosystems related to patient outcomes
Study
EGAS50000001474
-
10x Visium Spatial Transcriptomics of 61 Human Hepatocellular Carcinoma Samples
Dataset
EGAD50000002122
-
Hepatocellular Carcinoma Spatial transcriptomics Data Access Committee
Dac
EGAC50000000635
-
Epigenomic dataset of Human Hepatocellular Carcinoma for EpiHK
Study
EGAS50000000039
-
A prospective multicenter study of plasma ctDNA versus archival tumor tissue to guide FGFR-targeted therapy in metastatic urothelial cancer - Targeted
Study
EGAS50000001450
-
Targeted sequencing data of cfDNA, archival tissue, and WBC from 208 patients with mUC
Dataset
EGAD50000002089
-
Comprehensive Characterization of Early Relapse and End-Stage Relapsed Refractory Multiple Myeloma (HIPO K08K/H067/H021+nonHIPO)
Study
EGAS00001007469
-
Identification of New Therapeutic Targets for Renal Medullary Carcinoma via Integrated Genomic and Transcriptomic Profiling
Study
EGAS50000001280
-
Single cell RNA sequencing of relapsed/refractory multiple myeloma
Study
EGAS00001004805
-
Mutagenic impact of radiotherapy in B-cell lymphoma and multiple myeloma
Study
EGAS50000000997
-
Comprehensive genetic landscape, immune checkpoint profiling, and establishment of patient-derived xenograft (PDX) of metachronous brain tumors from constitutive mismatch repair deficiency with a biallelic variant on MSH6
Study
EGAS50000000351
-
Methylome of medulloblastoma data (MB_COMICS cohort)
Study
EGAS00001007815
-
DAC for study CMMRD–associated high-grade glioma
Dac
EGAC50000000855
-
Drug Perturbation of Primary Lymphoma Patient Samples and RNA Sequencing
Study
EGAS50000001500
-
RNA-seq after drug perturbation of primary lymphoma samples
Dataset
EGAD50000002166
-
PTEN homozygous deletion is a negative prognostic factor in Tumor Treating Fields-treated glioblastoma, IDH wildtype patients
Study
EGAS50000001469
-
Targeted DNA sequencing of TTFields-treated glioblastoma, IDH wildtype
Dataset
EGAD50000002117
-
TTFields Glioblastoma Data Access Committee, Charité – Universitätsmedizin Berlin
Dac
EGAC50000000843
-
STimage: Robust and interpretable prediction of gene markers and cell types from spatial transcriptomics data
Dataset
EGAD50000002172
-
Rare Germline Variants in CDKN2A-Negative Children and Adolescents with Cutaneous Melanoma
Study
EGAS50000001311
-
Exome data from 154 patients with childhood or adolescent cutaneous melanoma
Dataset
EGAD50000001868
-
Tumor-reactive heterotypic CD8 T cell clusters from clinical samples
Study
EGAS50000000785
-
Visium CytAssist Spatial Gene Expression analysis for FFPE glioblastoma samples
Study
EGAS50000001242
-
3D chromatin analysis of clear cell renal cell carcinoma using micro-C
Study
EGAS50000001323
-
Chromatin accessibility of clear cell renal cell carcinoma
Study
EGAS50000001325
-
ChIP-seq analysis of clear cell renal cell carcinoma
Study
EGAS50000001322
-
Gene expression analysis of clear cell renal cell carcinoma
Study
EGAS50000001324
-
Lymphoma_primary_patient_drug_perturbed_RNASeq_samples
Dac
EGAC50000000578
-
Recurrent COPA mutation drives R-spondin-independent Wnt activation in intestinal tumors
Study
JGAS000868
-
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations
Study
EGAS50000001272
-
Contribution of specific cell types to the development of Barrett’s esophagus and carcinoma via germline genetic risk
Study
EGAS50000000530
-
RNAseq profile of monomorphic epitheliotropic intestinal T-cell lymphoma and enteropathy associated T-cell lymphoma
Study
EGAS50000001125
-
Whole Exome Sequencing of monomorphic epitheliotropic intestinal T-cell lymphoma and enteropathy associated T-cell lymphoma
Study
EGAS50000001126
-
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
Study
EGAS00001000399
-
CASCADE metastatic melanoma study
Study
EGAS00001004950
-
Chordoma_Sequencing_Project_Whole_Genome
Study
EGAS00001000409
-
Recurrent Somatic Mutations of PTPN1 in Primary Mediastinal B cell lymphoma and Hodgkin Lymphoma
Study
EGAS00001000554
-
ICGC Oesophageal adenocarcinoma - pilot samples
Study
EGAS00001000559
-
Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma
Study
EGAS00001000579
-
Osteosarcoma_RNAseq
Study
EGAS00001000615
-
Whole Genome sequencing of adult T-cell leukemia/lymphoma
Study
EGAS00001001210
-
Identification_of_drug_resistance_genes_in_melanoma
Study
EGAS00001000617
-
Transcriptome sequencing of hepatocellular carcinoma biopsies (proteogenomic study)
Study
EGAS00001005074
-
Biallelic DICER1 mutations in sporadic pleuropulmonary blastoma
Study
EGAS00001000662
-
Radiation-induced gliomas represent H3-/IDH-wild type pediatric gliomas with recurrent PDGFRA amplification and loss of CDKN2A/B
Study
EGAS00001005243
-
Whole genome bisulfite sequencing of hepatitis B virus-associated hepatocellular carcinoma tumor and non-cancerous samples
Study
EGAS00001002230
-
Evolutionary predictability of genetic versus non genetic resistance to anticancer drugs in melanoma
Study
EGAS00001005314
-
Pediatric tumor in a single child of three large nuclear families
Study
EGAS00001005321
-
Burden_of_Disease_in_Sarcoma
Study
EGAS00001000087
-
Neuroblastoma tumor heterogeneity and cell plasticity (from patients)
Study
EGAS00001005322
-
UQCCR/QCMG brain metastasis sequence analysis
Study
EGAS00001000722
-
The mutational landscape of primary central nervous system lymphoma (Hipo H050, A050, XD013)
Study
EGAS00001005339